Cargando…

CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy

Donor lymphocyte infusion (DLI) followed by hematopoietic stem cell transplantation has served as an effective prevention/treatment modality against the relapse of some hematologic tumors, such as chronic myeloid leukemia (CML). However, the therapeutic efficacies of DLI for other types of leukemia,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hyung Bae, Lee, Ji Eun, Oh, Yu Mi, Lee, Sang Jin, Eom, Hyeon-Seok, Choi, Kyungho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565951/ https://www.ncbi.nlm.nih.gov/pubmed/28751785 http://dx.doi.org/10.1038/emm.2017.104

Ejemplares similares

Donor Bone Marrow-Derived T Cells Inhibit GVHD Induced by Donor Lymphocyte Infusion in Established Mixed Allogeneic Hematopoietic Chimeras
por: Wang, Hui, et al.
Publicado: (2012)

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
por: Gao, Xiao-Ning, et al.
Publicado: (2018)

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes
Publicado: (1992)

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
por: He, Yonghan, et al.
Publicado: (2020)

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
por: He, Fiona, et al.
Publicado: (2016)

Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome
por: Park, Silvia, et al.
Publicado: (2021)

CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation
por: Lingel, Holger, et al.
Publicado: (2017)

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28
por: Lin, Hua, et al.
Publicado: (1998)

Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4(+)CTLA4(hi) T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade
por: Ezzelarab, Mohamed B., et al.
Publicado: (2018)

Understanding anti-leukemia responses to donor lymphocyte infusion
por: Bachireddy, Pavan, et al.
Publicado: (2014)

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia
por: Reagan, J L, et al.
Publicado: (2015)

Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008
por: Park, Hyeon Jin, et al.
Publicado: (2012)

Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia
por: Rujkijyanont, P, et al.
Publicado: (2013)

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells
por: Kwon, Yong-Rim, et al.
Publicado: (2020)

In irradiation chimeras, K or D regions of the chimeric host, not of the donor lymphocytes, determine immune responsiveness of antiviral cytotoxic T cells
por: Zinkernagel, RM, et al.
Publicado: (1978)

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
por: Bouwhuis, Marna G., et al.
Publicado: (2009)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
por: Stadler, Michael, et al.
Publicado: (2022)

Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes?
por: Sergeevichev, David, et al.
Publicado: (2022)

Matched Developmental Timing of Donor Cells with the Host Is Crucial for Chimera Formation
por: Cohen, Malkiel A., et al.
Publicado: (2018)

Analysis of hematologic parameters of donors, patients, and granulocyte concentrates to predict successful granulocyte transfusion
por: Lee, Jong-Mi, et al.
Publicado: (2019)

Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma
por: Schober, Sebastian J., et al.
Publicado: (2018)

Graft‐versus‐mastocytosis effect after donor lymphocyte infusion: Proof of principle
por: Hägglund, Hans, et al.
Publicado: (2020)

Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusion
por: McCurdy, Shannon R.
Publicado: (2022)

CTLA-4-Tg/CD-28-KO Mice Exhibit Reduced T Cell Proliferation in vivo Compared to CD-28-KO Mice in a Graft-versus-host Disease Model
por: Yoo, Jong-Sun, et al.
Publicado: (2012)

Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy
por: Shin, Jae Hun, et al.
Publicado: (2016)

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
Publicado: (1995)

Irradiation of peripheral blood mononuclear cells with 7.5 Gy X-rays prior to donor lymphocyte infusion inhibits proliferation while preserving cytotoxicity, and improves the effectiveness of HSCT in patients with hematological malignancies
por: Wei, Yong-Qiu, et al.
Publicado: (2017)

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation
por: Gagelmann, Nico, et al.
Publicado: (2023)

Low incidence and morbidity of Epstein‐Barr virus reactivation following donor lymphocyte infusions
por: Martinovic, Danilo, et al.
Publicado: (2023)

Hematological Changes and Reference Intervals in Hanwoo Calves during the First 28 Weeks of Life
por: Kim, Ui-Hyung, et al.
Publicado: (2021)

Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
por: McDaniel, Jessica M., et al.
Publicado: (2012)

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia
por: Mittal, Amit K., et al.
Publicado: (2013)

Expression patterns of CD28 and CTLA‐4 in early, chronic, and untreated rheumatoid arthritis
por: García‐Chagollán, Mariel, et al.
Publicado: (2020)

Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia
por: Frydecka, I, et al.
Publicado: (2004)

The search for the chimera
por: Randi, J
Publicado: (1991)

Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia
por: Su, Qiongqiong, et al.
Publicado: (2021)

Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology
por: Lee, Hyun Tae, et al.
Publicado: (2019)

Immunotherapy with cure potential of multi-drug resistant hematologic malignancies using IL-2 preactivated intentionally mismatched donor lymphocyte
por: Slavin, Shimon
Publicado: (2023)

Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
por: Markouli, Mariam, et al.
Publicado: (2022)

Association of CTLA4 Gene Polymorphism with Transfusion Reaction after Infusion of Leukoreduced Blood Component
por: Wen, Ying-Hao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_al7dfe9u72l55fuj1b70k9bjp3